Have a personal or library account? Click to login
Increasing Evidence for the Use of Sodium Oxybate in Multi-Drug- Resistant Lance–Adams Syndrome Cover

Increasing Evidence for the Use of Sodium Oxybate in Multi-Drug- Resistant Lance–Adams Syndrome

Open Access
|Jun 2019

Abstract

Background: Treatment of posthypoxic myoclonus (PHM) can be a challenge in patients not responsive to first-line medications. PMH is a rare condition that has a dramatic impact on patients’ quality of life. Refractory cases are not uncommon.

Case report: We report a patient with PHM non-responsive to conventional treatments who showed a dramatic improvement with sodium oxybate (SBX). Cases of PHM treated with SBX reported in the literature were reviewed.

Discussion: Resting and stimulus-induced myoclonus respond robustly to SBX, with significant improvement in patients’ quality of life. SBX may be considered in patients with PHM resistant to first-line medications.

DOI: https://doi.org/10.5334/tohm.472 | Journal eISSN: 2160-8288
Language: English
Submitted on: Jan 24, 2019
Accepted on: Mar 4, 2019
Published on: Jun 17, 2019
Published by: Columbia University Libraries/Information Services
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2019 Giulietta M. Riboldi, Steven J. Frucht, published by Columbia University Libraries/Information Services
This work is licensed under the Creative Commons License.